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In search of better scaffolding materials for in vitro culture of chondrocytes, the
combination of chitosan (similar to glycosoaminoglycans) and gelatin (denatured
collagen) was tested due to its resemblance to cartilage extra-cellular matrix (ECM).
Porous scaffolds were fabricated from chitosan gelatin blends (1:1, 2:1, and 3:1).
The response of chondrocytes to them was evaluated from the amount of sulphated GAG
and collagen type 2 secreted after 3 and 5 weeks. The effect due to static (transwell
inserts) and dynamic (rotating bioreactor) culture methods was analyzed.
Results indicate that 1:1 chitosan gelatin blends showed the best chondroconductive potential. The rotating bioreactor facilitated better cell distribution across
scaffold but did not show higher ECM secretion compared to transwell culture after 3
weeks. Gelatin leeched out by dissolution in culture media and left an open and
interconnected chitosan network. Chitosan gelatin scaffolds show a potential for use in
cartilage tissue engineering applications.
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CHAPTER I
INTRODUCTION AND BACKGROUND REVIEW

Arthritis and Cartilage Repair

Prevalence
According to The Centers for Disease Control and Prevention, in 2002 1 out of 5
(i.e. about 43 million) American adults reported doctor-diagnosed arthritis and another 23
million reported symptoms similar to chronic arthritis. In 1997 the medical care for
arthritis cost $51 billion. Arthritis occurs irrespective of racial and ethnic groups, and
about two-thirds of people with arthritis are below 65 years (The Center for Disease
Control and Prevention, 2005).
Arthritis is comprised of a group of over 100 diseases and conditions of which
osteoarthritis, gout, Rheumatoid arthritis, and fibromyalgia are the most common. These
conditions follow a certain sequence of events like proteoglycan washout from the
extracellular matrix, disruption of the collagen network, and metaplasia, and the
superficial focal regions of the defect gradually progress deep into the cartilage tissue
(Hunziker, 2001). Unlike other tissues like bone and skeletal muscles the lesions in
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cartilage generally do not heal as effectively. Since cartilage acts as a lubricating
membrane between the ends of moving bones, loss in its consistency eventually causes
severe wear and tear of contacting bones, accompanied by pain. Other orthopaedic
complications become prominent eventually.
Repair of Cartilage Lesions
The avascularity, low metabolic activity, and catabolic activity of chondrocytes
are reasons that may have lead to the 200 year old dogma “Cartilage once destroyed
never heals” (Hunter, 1743). Current research shows these lesions in cartilage do heal
under some biological circumstances, which include untreated cartilage defects. Articular
cartilage repair and/or regeneration may occur only in the region of defect and only if
there are adequate “stimuli” for such activity. This repair process is initiated when the
defect in cartilage reaches subchondral bone and bone marrow and causes bleeding from
blood vessels (Hunziker, 2001). This leads to formation of hematoma and fibrin clot and
encourages accumulation of certain morphogenetic proteins, and glycoproteins, growth
factors released by the bone (Reddi, 1999). Progenitor cells like mesenchymal stem cells
and fibroblast migrate from the surrounding cartilage, bone, underlying bone marrow,
and synovium into the repair site in about two to five days. These play an important role
in initiating and maintaining the repair process (Shapiro et al., 1993, Hunziker, 2001).
After about a week of infiltration of stem cells, the fibrin network from the blood clot
serves as a scaffold for growth and differentiation of mesenchymal stem cells. The repair
process is limited by the diameter of the full thickness defect created in experimental
models. Varying from species to species, small defects of about 1-3 mm diameter are
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seen to heal spontaneously. Large defects approaching 6 mm in diameter were not seen to
heal well in a goat model (Jackson et al., 2001). The depth and location of the defect, age,
and body mass of the animal are other considerations that may affect the repair process.
In a small defect spontaneously generated repair tissue fills it completely in few
months, but its integration with the native cartilage is questionable. Shapiro et al., (1993)
report, in their rabbit model, full thickness defects (3mm diameter) were filled with
loosely integrated repair tissue, in four weeks. But even after eight weeks, the lacunae at
the boundary of the defect remained empty with low or no chondrocytic activity seen in a
layer about three to eight cells deep. In fact, chondrocytes in adjacent layers of the defect
die within few hours of drilling the defect. Eventually, signs of degeneration of the repair
cartilage were seen after 12 weeks and these remained a prominent feature thereafter. The
heterogeneous biochemical composition of the repair tissue and its inferior biomechanical
properties may lead to micromotion between the boundaries of both cartilages, and this
may initiate a degradation response (Shapiro et al., 1993, Hunziker, 2001).
Surgical Interventions
Surgical

techniques

like

Pridie

debridement

(Insall,

1974),

Abrasion

chondroplasty (Chen et al., 1999), and Microfracture (Stedman et al., 1999) are based on
the principle of causing forced bleeding in the cartilage defect by drilling deep into the
defect until the subchondral bone is reached. The microfracture technique has shown
encouraging results. Since it is less expensive, yet effective, it is a widely adopted clinical
procedure especially for young individuals (Kinner and Spector, 2004). Extensive
surgeries like arthroplasty replace the weakened joints or their components with artificial
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joints or parts. Osteotomy involves improving the biomechanical load transfer and
alignment at the joint to achieve pain relief (Hunziker, 2001).
Long term clinical trials have shown that cell based therapies using autologous
chondrocyte implantations are effective to help regenerate tissue close to healthy hyaline
cartilage (Peterson et al., 2000). Therapies like autologous periosteal grafting
(O’Driscoll, 1999), autologous perichondrial grafting (Bouwmeester, et al. 1997), and
osteochondral transplantation (Hangody et al., 1998) have also attained clinical
significance due to various reasons. The results of autologous periosteal grafting look
promising from short term clinical study reports, but there are no controlled trials
performed to prove their effect.
The quality of the repair tissue developed in the cartilage lesion is influenced by
type, location, and number of lesions worked on in a single joint. The source of implanted
cells, alignment and loading at the joint, and disease conditions may also have an
influence on the repair process (Kinner and Spector, 2004). Although the associated pain
relief and fair mechanical properties of the resultant tissue make these procedures
clinically acceptable, the histological integrity of the tissue may be considered a better
marker for the evaluation of joint and cartilage health.
Tissue Engineering Based Approaches for Cartilage Repair
Tissue engineering may be defined as the application of principles of cell biology,
material science, engineering, and surgery to the regeneration and implantation of
functional tissue or its components either in vitro, in vivo or both (Goldberg and Caplan,
2004). Given the low activity of chondrocytes and the avascularity and complexity of the

5
cartilage extra-cellular matrix, the process of regeneration of articular cartilage becomes
complicated and challenging. Even for a surgical defect that penetrates the subchondral
bone, the resulting repaired cartilage tissue is closer to a fibrocartilagenous phenotype
and may have significantly different mechanical properties compared to the native
articular cartilage (Kinner and Spector 2004). Since the repaired fibrocartilage is not very
well integrated with the surrounding tissue, it has a possibility to rupture eventually. Also
the loading causes fibrocartilagenous tissue to have a tendency towards ossification.
These limitations may be circumvented, (at least partially if not fully) using novel
biomaterials modified by sophisticated tissue-engineering techniques that allow precise
control over cellular behavior both in vitro and in vivo. Customized biomaterial implants
may prove to be beneficial if used in combination with conventional surgical and cell
based therapies. The overall goal during this process is to bring the phenotype of repair
cartilage closer to that of a healthy articular cartilage.
Even if such trend is achieved from in vitro culture, the in vivo performance of the
engineered tissue and its integration with the native tissue posseses further challenges.
These practical limitations restrict the use of only tissue engineering techniques as a
clinically suitable treatment option. Using engineered tissue along with surgical
procedures like debridement or osteochondral drilling seems a viable alternative at this
stage.
Biomaterials and Tissue Engineering Techniques
As a first step, the selection biomaterial for the implant is important. Apart from
being less cytotoxic (more biocompatible), specific requirements on the material may be
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based on the conditions at the implant site. Table 1 summarizes some of the important
requirements. If the material needs to be implanted temporarily, it should be
biodegradable; if used for long-term implantation, it should be less susceptible to
mechanical degradation. The substances released from the degradation should not be
harmful to the body and must be easily converted and/or transported. The material should
be easier to fabricate into implants of required shapes and its mechanical properties
should be controllable and customizable as required for the implant site (Hunziker 1999).
The bonding capabilities, surface characteristics, remodeling capacity and overall
architecture are other considerations (Goldberg and Caplan, 2004).

Table 1: Biological effects corresponding to properties of matrix. Modified from
Hunziker and Ernt (1999)

Matrix Characteristics

Biological response or effect

Porosity

Cell migration inside matrix hence uniform distribution of
newly grown tissue

Chemical properties of

Aids in cell attachment and signaling in cell environment

component

Aids accumulation and organization of ECM components

biomaterial(s)

Allows release of bioactive substances

Biocompatibility

Cell viability and tissue response

Biodegradability

Aids tissue remodeling

Gross mechanical

Affects cell growth and proliferation response

properties

In-vivo load bearing capacity

Structural anisotropy

Anisotropic growth & tissue organization
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Considering cell loss due to the massive apoptotic response (Mao et al., 2004) to
cells in the first few hours of contact with the material, a high cell seeding density is
required. The cell seeding technique should be such that it would give a uniform
distribution in the loading matrix.
Generally there are two strategies followed for tissue engineered implants. A near
mature cartilage tissue may be cultured in vitro and later implanted in the cartilage defect.
This method is demands considerable amount of time and poses concerns on the
integration of the implanted tissue with surrounding tissue. Lack of proper binding
between these tissues possibly leads to micromotion between them and hence failure of
the implant. Another strategy would be to implant the defect with tissue construct that has
an immature tissue grown on it. Since this demands lesser amount of time in in vitro
culture there is a better possibility of maintaining chondrocyte phenotype. Chondrocytes
from the immature tissue may migrate and bridge the surrounding tissue and integrate
well.
In a healthy cartilage the chondrocytes monitor the extra cellular matrix and
control and regulate its secretion in response to mechanical and chemical stimuli
(Caterson et al., 2004). Improper signaling in the cartilage environment causes them to
change their phenotype to more of a fibrocartilage type. For efficient in vitro culture that
would preserve chondrocyte phenotype, the required chemical and mechanical signals
must be supplied. The requirements of a high seeding density are met by using a porous
3D scaffold matrix for cell culture. The porous structure gives a high surface area to
volume ratio and keeps the cells attached in a very close proximity. Further, an
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interconnected porous structure facilitates cell migration deep inside the matrix. For a
uniform filling of the scaffold with newly grown tissue the viability of cells attached deep
inside is maintained. These mass transport and diffusional limitations of the porous
structure may be eliminated by selection of proper culture conditions.
Aerobic culture conditions were seen to enhance chondrogenesis in 3D polymer
constructs developed by Obradovic et al. (1999). Vunjak-Novakovic et al. (1999) report
cell-seeded polymer constructs cultured in a rotating cell culture bioreactor showed much
higher secretion of collagen and glycosoaminoglycans (GAG) as compared to those
cultured in other culture techniques like spinner flask, orbital mixing, and solid body
rotation. Chondrocytes cultured on PGA constructs, in a rotating bioreactor, for six weeks
had composition and mechanical properties comparable to an immature fetal cartilage
while these values were comparable to the native cartilage after seven months. A gradient
in concentration of sGAG and a uniformly proliferated cartilaginous matrix was observed
after six weeks (Vunjak-Novakovic et al., 2004). This makes the selection of culture
conditions important. Intermittent hydrostatic loading on chondrocytes is seen to
modulate Agrecan and type II collagen expression (Smith et al., 2004, Ikenoue et al.,
2003). These factors demonstrate the importance of culture techniques.
Typically the evaluation of a biomaterial implant is preceded with an extensive
confidence from its in vitro cellular response to the tissue of interest. In order to access
the in vivo biocompatibility of the material, a heterotopic model may be employed. Here
the implant performance is evaluated by placing the implant in a subcutaneous pouch
generally in a small animal model (mice, rabbit etc.). If an acceptable response is seen a
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large animal model (goat, dog etc) may be employed to simulate conditions similar to
those in a human body. Here the biomaterial is implanted into a full thickness defect
drilled deep up-to subchondral bone. Practical and fiscal limitations prevent usage of
large animals for preliminary studies (Reinholz et al., 2004). Extensive clinical trials may
be performed in animals and the same procedure repeated with human cells.
Chitosan as a Biomaterial
Chitin is a linear polysaccharide found in marine crustacean shells and the cell
walls of bacteria and fungi (Mi et al., 2001). It is the second most abundant natural
polymer after cellulose. Chitosan (with repeating units of β (1-4) 2-amino-2-deoxy-Dglucose) is a deacetylated (40-98%) derivative of chitin having molecular weight about
300 KDa to 2000 KDa (Nettles et al., 2002, Di Martino et al., 2005). Chitosan is known
to have some unique physiochemical, biomedical and pharmaceutical properties, which
have wide range applications in tissue engineering and orthopedics, pharmaceutics, food
industry, cosmetics, agriculture, and waste management etc. Chitosan is generally
insoluble at neutral and alkaline pH but forms salts with organic acids at low pH (Illeum,
1998). The degree of deacetylation and preparation methods influence the crystalanity
and molecular weight of chitosan obtained.
Chitosan is structurally similar to glycosaminoglycans (GAGs), which are long
unbranched polysaccharides found in extra cellular matrices (ECM) of some connective
tissues. (Hamilton et al., submitted). Chitosan and its derivatives are known to be
bacteriostatic (Yang et al., 2005), fungistatic, antimicrobial, antiinflammatory,
antioxidant and antimutagenic (Mi et al., 2001, Seo et al., 2003, Tomihata et al., 1997,
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Kogan et al., 2004). The antiinflamatory properties of chitosan may be attributed to its
inhibition of over-production of prostoglandins E2 and pro-inflammatory cytokines, such
as tumor necrosis factor-alpha produced by macrophages (Chou et al., 2003).
The protonation of amine group of chitosan on its dissociation imparts it a
cationic nature (Illeum 1998), which helps cell adhesion by allowing attachment of
anionic cell membrane proteins and growth factors (Chatelet et al., 2001) as seen from
the hemagglutination response on contact with blood (Lee et al., 1995, Onishi and
Machida 1999, Tomihata and Ikada, 1997, Rao and Sharma, 1997). Higher the degree of
deacetylation higher is the number of amide groups available for protonation and hence
better is cell adhesion (Mao et al., 2004).
Due to its hemostatic properties (Rao and Sharma 1997) chitosan is reported to
have many wound healing applications like wound and burn dressing material (Kato et
al., 2003, Muzzarelli et al., 1999), and fluid absorbing chitosan beads (Yusof 2001). It
has numerous pharmaceutical applications like tablets, gels, oral mucoadhesive, drug
delivery microgranules (Gupta and Ravi Kumar, 2000), non-viral gene delivery
transfection vehicle (Borchard, 2001) and many more as reported by Illeum (1998) and
Kato et al. (2003).
Biodegradation of Chitosan
Since chitosan is a polysaccharide, its primary mechanism of in vivo degradation
is through enzyme hydrolysis that is triggered by lysozyme and not by human chitinase
(Varum et al., 1997). The degradation is dependant on the pH, type and method of
preparation of chitosan (Nettles et al., 2002). Lysozyme is an enzyme abundantly found
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in blood and cartilage extra cellular matrix and is also secreted by chondrocytes (Moss et
al., 1997).
Degree of deacetylation (DDA) has a notable effect on the rate of degradation of
chitosan (Hirano et al 1989, Shigemasa st al.1994, Tomihata and Ikada 1997). Higher the
DDA slower is the rate of degradation. The cationic nature of chitosan is chemotractant
to negatively charged cell surface proteins (Chung et al., 2003) and so higher the DDA
higher is the cell attachment and severe is the tissue response and subsequent cell
apoptosis. Tomihata and Ikada (1997) observed that chitosan films with high DDA
(>73%) showed less degradation by lysozyme in vitro and in vivo, when implanted
subcutaneously in rats. This implies material properties like hydrophilicuty and molecular
weight also play a role in the in vivo degradation and overall performance of chitosan.
Although not much consistent data is reported, the lysozyme-induced depolymerization
process yields mostly non-toxic oligosaccharide residues, which are easily excreted by
the body (Nettles 2001, Onishi and Machida 1999). Overall, these finding suggest better
biocompatibility of chitosan.
3-D Scaffolds from Chitosan —What Have We Learned?
Each tissue has its own specific requirements from the implanted biomaterial. A
versatile polysaccharide like chitosan presents promising possibilities for customization
to cell and tissue specific culture conditions. Due to its low cytotoxicity, biodegradability,
cationic nature, and chemical similarity to GAG and hyaluronic acid, chitosan is blended
with other ECM components to simulate a more cartilage-like environment in the
scaffold/construct. Although using chitosan alone may seem to be promising in some in
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vitro models, its limitations to degradation and specific chemotaxic effects (Peluso et al.,
1994) may be of concern for long-term in vivo implantation.
Traditionally, porous scaffolds from chitosan are fabricated by dissolving it in an
organic acid such as acetic acid (1 to 3% v/v) followed by freezing and lyophilizing. In
lyophilization the liquid components of the solution, in form of ice crystals, are removed
by subjecting it to vacuum. The dissolved chitosan is left behind in a highly
interconnected porous matrix structure. As would be expected, the pore size of the
resulting scaffold depends on the size of nucleated ice crystals during freezing of the
solution. Lower the freezing temperature, faster is the rate of ice formation and smaller is
the size of ice crystals that are formed resulting in a small scaffold pore size (Nettles,
2001). Porous scaffolds may also be constructed by internal bubbling process (Chow and
Khor, 2000). Chitin solution was loaded with Calcium carbonate (CaCO3) to form gels.
These gels were then submerged in HCl to give a highly porous matrix. Release of CO2
on the reaction of CaCO3 and HCl helps to form bubbles in the gel matrix. This process
resulted in scaffolds with larger pores diameter (100-500 and 500-1000µm) as compared
to those from lyophilization (40-100µm) by Nettles et al. (2002). Geng et al., (2005)
manufactured chitosan scaffold using a desktop rapid prototyping system. Here, the
solution of NaOH in ethanol was used to neutralize acetic acid from chitosan solution to
form porous scaffolds of about 90% porosity and pore diameter 200-500µm. The system
seems promising to develop highly ordered porous chitosan scaffolds of required shape
and porosity.
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3D Scaffolds from Chitosan Gelatin Blends
Chitosan based scaffolds and/or films were constructed by blending it with
molecules like collagen (Ma et al., 2003), GAG (Madihally and Mathew, 1999), alginate
(Iwasaki et al., 2004), lactose (Donati, 2005), poly(L-lactic acid) (Cui et al. 2003),
hyaluronic acid (Yamane et al., 2005), calcium phosphate (Zang and Zang, 2001), and
gelatin (Mao et al., 2004, 2003, 2002, Xia et al., 2004, Zhao et al., 2001). Chitosan is
also used extensively for surface modification of biomaterials and implants (Bumgardner
et al., 2003). These chitosan based/modified constructs are explored for in vitro and in
vivo tissue engineering applications for different tissues including cartilage, bone,
ligament and skin.
Gelatin is basically partially denatured collagen obtained by breaking its triple
helix structure mostly by hydrolysis. If used in its pure form it is known to be hemostatic
as seen from the presence of an acute in vivo inflammatory response and increased
neutrophil activity (Burugapalli et al., 2003, Rose et al., 1989). These characteristics may
be attributed to the anionic nature of gelatin. This charge may be balanced by complexing
it with cationic molecules like chitosan. Moreover, the hydrophilicity of gelatin due to its
amino and carboxyl groups helps in improving water retention and oxygen and nutrient
transfer throughout the scaffold architecture (Xia et al., 2004).
Zhao et al., (2002) prepared a 3-D hydroxyapatite chitosan gelatin network
scaffold by cross-linking the components with glutaraldehyde. After 7-day culture of
osteoblast on these scaffolds good cell attachment and proliferation was seen, and osteoid
formation and mineralization of scaffolds was seen after 21 days.
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Mao et al., (2003) prepared monolayered and bilayered scaffolds by setting a
thermal gradient in the chitosan and gelatin mixture while freezing. Glutaraldehyde was
used as a cross-linking agent. The mixture was brought in contact with a pre-cooled plate
and frozen for few hours followed by lyophilization. The mean pore size in the bilayered
scaffold varied from about 30µm (freezing plate interface) to 110µm (air interface) and
resulted in highly ordered cylindrical pores. Reducing the initial freezing temperature
from –20º C to –60º C for the monolayered scaffolds decreased the mean pore size from
210µm to 115µm. Scaffolds with lesser pore size (-60ºC) degraded faster due to lysozyme
activity. Similarly, membranes (films) prepared from chitosan gelatin polyelectrolyte
complex showed improved hydrophilicity as compared to pure chitosan films (Mao et al.,
2004). A polyelectrolyte complex is a loose association between two or more ionic or
covalent molecular entities. Since chitosan has a tendency to form weak hydrogen bonds
with gelatin, its high positive charge density due to its DDA may be shielded by
complexing it with gelatin. The cell cycle analysis performed through flow cytometry
indicated that chitosan gelatin film is more biocompatible to trigger L929 cell
proliferation and results in lesser number of apoptic cells as compared to pure chitosan.
DDA was not seen to affect cell cycle progression (Mao et al., 2004). In another study,
Mao et al. (2003) reported chitosan gelatin membranes modified by hyaluronic acid
showed better fibroblast proliferation compared to pure chitosan and pure gelatin
membranes, after 11 days of culture. Also blending hyaluronic acid in the chitosan
gelatin scaffold made it slightly less degradable and showed higher GAG concentration
after in vitro fibroblast culture. As a potential artificial skin substitute, chitosan gelatin
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scaffolds (Liu et al., 2004) and chitosan gelatin hyaluronic acid scaffolds (Mao et al.,
2002) supported growth of fibroblasts co-cultured with keratinocytes. The modified
scaffolds showed better cell proliferation and penetration of spherical keratinocytes into
scaffold pores and secretion of matrix after culturing for 4 weeks. The hydrophilicity of
hyaluronic acid seems to help the binding of peptides and growth factors to culture
substrate. Similarly, chitosan gelatin membranes prepared by Cheng et al., (2003)
showed higher neural cell affinity and proliferation as compared to pure chitosan
membranes but were about the same as pure gelatin films.
Xia et al. (2004) prepared porous scaffolds with equal parts of chitosan and
gelatin solutions. The resultant bilayered scaffold had a mean pore size ranging 60200µm in diameter. After in vitro culture of auricular chondrocytes on them for 7 days,
they were subcutaneously implanted into pig abdomens. These cell seeded constructs,
when harvested after 10 and 16 weeks showed generation of ECM and
neochondrogenesis, while the chitosan gelatin controls scaffolds without chondrocytes
were completely degraded in 16 weeks. The cartilage tissue developed after 16 weeks had
GAG levels 89% of native auricular cartilage and similar biomechanical properties.
Risbud et al., (2001) cultured human nasal septal cartilage on cover slips coated
with freeze-dried chitosan gelatin hydrogels and films (3:2 w/w). The cells maintained
chondrocytic phenotype and secreted ECM after 14 days of culture. This was confirmed
from RT-PCR analysis, which showed significant expression of type II collagen
compared to type I and III. Elcin et al. (1998) showed chitosan gelatin membranes to
support higher cell attachment as compared to chitosan collagen and pure chitosan
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membranes. Similarly others have reported pure collagen to be more cytotoxic as
compared to pure gelatin (Burugapalli et al., 2003).
In a more recent study on chitosan gelatin blended scaffolds (1:3, 1:1, and 3:1)
cultured with Human umbilical vein endothelial cells (HUVEC) and Mouse Embryonic
Fibtoblasts (MEF), no significant stimulatory effect was observed due to the presence of
gelatin in scaffolds (Huang et al., 2005). Cross-linking of scaffolds with 0.25%
glutaraldehyde significantly decreased their degradation rate and made them harder to
handle after 24 hours. These cells when cultured on chitosan gelatin (1:1) membranes for
2 days had higher cell spreading area as compared to pure chitosan membranes as seen
from their fluorescence micrographs stained for actin filaments. The amount of gelatin in
chitosan scaffolds did not appear to affect cell viability on 3D scaffolds (Huang et al.,
2005). Also, the compressive elastic moduli of chitosan gelatin scaffolds with 25% and
50% gelatin were not significantly different from that of pure chitosan scaffolds.
For potential use of chitosan gelatin scaffolds for cartilage repair applications it
may be useful to control the rate of degradation of the implant depending on the species,
pathological condition of cartilage, and the age of the patient. Glutaraldehyde crosslinking prolongs degradation of chitosan (Jameela and Jayakrishnan, 1995, Huang et al.
2005). Pure gelatin, as well as gelatin films cross-linked with glutaraldehyde more than
66%, showed persistent in vivo acute tissue response after 3 months (Burugapalli et al.,
2003). This response may be due to cytotoxicity of glutaraldehyde released out of the
implants and its degradation products (Jayakrishanan and Jameela, 1996). The cross
linking scheme may be useful to extend the in vivo degradation rate of chitosan based
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drug delivery systems (Li et al., 2004), which are subjected to high enzymatic activity
from the systemic system. The relatively low metabolic activity of cartilage demands
scaffolds that are easily degradable by low enzymatic activity of regenerating
chondrocytes. Glutaraldehyde cross-linking cleaves away acetyl groups from chitosan.
These play an important role in lysozyme mediated enzymatic degradation of chitosan.
Since articular cartilage is avascular, the toxic glutaraldehyde degradation products may
not be effectively transported away from the implant site and their accumulation would
cause more inflammatory response, which may interfere with the process of
chondrogenesis. Hence having the scaffold to degrade faster would balance the
degradation rate to the rate of regeneration of new cartilage by cultured cells.
The studies cited above show adequate evidence of biocompatibility and
chondrogenic characteristic of the combination of chitosan and gelatin. Gelatin is known
to be less antigenic compared to its precursor collagen. Since chitosan and gelatin are
chemically similar to two most essential components of cartilage ECM, viz. GAG and
collagen, their combination in a 3D scaffold may effectively simulate ECM for an in vitro
culture of articular chondrocytes.
Chitosan Scaffolds – Future Directions
Cell adhesion and proliferation on the scaffold are influenced not only by the
DDA but also the surface structure of the scaffold. Wang et al. (2003) report that surface
modification of chitosan films using specific lectin molecules was seen to improve cell
adhesion and the resulting oligosaccharide mediated cell adhesion may also help in cell
proliferation.
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Chitosan protects the activity of Fibroblastic Growth Factor-2 (Masuoka 2005),
and hence may act conductive for tissue generation. Chitosan is seen to increase activity
of growth factors like Transforming growth factor (TGF)-β, Platelet derived growth
factor (PDGF) (Ueno et al., 2001), and Interleukin-1, which provide necessary signaling
for growth and proliferation of chondrocytes (van der Kraan et al., 2002).
Typically, any biomaterial implant, which is to be used for in vitro cell culture,
must be fabricated in such a way that it adequately replicates the conditions of native
tissue environment, as closely as possible. The porosity of 3-D scaffolds facilitates cell
attachment and hence maintains a high chondrocyte density, which in turn helps to
conserves their phenotype.
Articular cartilage chondrocytes rely on cell signaling mechanisms through
integrins, growth factors (TGF-β, PDGF, BMP-2) and interleukins, for their growth and
differentiation (van der Kraan et al., 2002). These mechanisms enable them to transduce
the mechanical environment of the joint and maintain ECM as required. These growth
factors may be supplemented along with the culture medium used for the cell-seeded
scaffolds or may be integrated in the scaffold matrix itself in the form of microspheres
(Kim et al., 2003). Lee et al. (2004) report that the scaffolds constructed by complexing
chitosan with other components of extra cellular matrix, like chondroitin sulphate, GAGs,
collagen and growth factor TGF, showed significant high proliferation rate and secretion
of GAGs.
Instead of adding growth factors to the culture medium, gene encoding for these
growth factors may be incorporated in the cells itself. Transfection of TGF-β1 by
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retroviral vectors has been reported to increase matrix synthesis for meniscal cells (Goto
et al., 2000). Similar encouraging results were reported for nonviral transfection of TGFβ1 in osteochondral defect in a rabbit model (Goomer et al., 2000). Chitosan is shown to
have a potential of non-viral gene transfection vector (Borchard, 2001, Mansouri et al.,
2004). Non viral transfection using chitosan DNA complexesmay be a better way to
supply regulatory molecules for in vitro culture. Currently used gene transfection
methods may not deliver regulatory signals in specific spatio-temporal patterns as
required (Madry and Trippel, 2000). This limitation may be overcomed, at least partially,
by employing matrix based transfection vectors that may be released to the chondrocytes
at a controlled rate. Non-viral gene transfection vectors do not pose the risks of toxicity
and immunogenenic response, which are common for viral vectors (Lieberman, 2004).
However, their performance for long term in vitro culture is limited by the fast release
characteristics of these agents.
Chondrocytes, once harvested from the patient may be cultured in vitro on these
modified 3-D scaffolds along with necessary chemical and mechanical stimuli from
culture environment. An immature neo-cartilaginous tissue that may result this way may
be implanted in a freshly created subchondral bone defect. The porous scaffolds would
absorb and retain the blood oozing from the defect. This would accelerate fibrin clot
formation in the defect and initiate a local immunological response. This clot would serve
to be chemo-attractant to the stem cells from bone marrow and necessary growth factors
for chondrogenesis. Electrochemical charges on the matrix components play an important
role to either hold or repel matrix growth factors and proteins. The cationic nature of
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chitosan would not only aid in initial cell adhesion, but it may also hold anionic growth
factors like Bone Morphogenic Proteins from the matrix. This would help the attached
cells to preserve their chondrocyte phenotype. With a carefully selected post surgery
protocol followed a fairly good integration of newly growing tissue may be achieved.
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Statement of Hypothesis
The combination of chitosan and gelatin in form of a porous 3D scaffold helps to
simulate the structure and chemical composition of the environment in native articular
cartilage in vitro. It was hypothesized that gelatin blended chitosan scaffolds combined
with a dynamic culture technique would show a higher secretion of cartilage extra
cellular matrix components and hence, help to maintain chondrocytic phenotype, more
effectively as compared to pure chitosan scaffolds in an in vitro static monolayer culture.
The amount of GAGs and collagen secreted by the cultured chondrocytes was used to
quantify the extent of growth and proliferation of chondrocytes in response to the
variation in concentration of gelatin in the 3D chitosan scaffold. Further, the effect due to
in vitro static and dynamic culture methods was evaluated using the same parameters
along with the compressive resilience elastic modulus.
Aims
To evaluate the chondrogenic potential of chitosan gelatin scaffold for in vitro
culture of chondrocytes.
Objectives
•

Prepare porous scaffolds from chitosan gelatin blends.

•

Evaluate the long-term cell viability and proliferation of chondrocytes cultured on
chitosan gelatin scaffolds.

•

Evaluate the effect due to static and dynamic culture methods on chondrocytes
cultured on these scaffolds.

CHAPTER II
EXPERIMENTAL DESIGN & METHODS

Experimental Design
The overall goal of this project is to design constructs for the repair of cartilage
lesions. For this purpose, the scaffolds should support chondrogenesis and secretion of
ECM and degrade at a rate similar to the rate of growth of native cartilage tissue. This
ensures better integration of the developing new tissue with the existing native cartilage.
The in vivo degradation rate of chitosan depends on factors like degree of deacetylation
(DDA), preparation and pretreatment methods of chitosan along with the porosity and
preparation method of implanted constructs.
Since the pretreatment of chitosan, such as the sterilization method, may alter its
properties care was taken of not exposing it to strong chemicals or ionizing radiation.
Scaffolds were prepared by freezing and lyophilizing blends with varying concentrations
of chitosan and gelatin solutions in acetic acid.
In order to test the effect due to gelatin concentration in the blend, three scaffolds
each were prepared having chitosan to gelatin ratio 1:1, 2:1 and 3:1 (w/v) while pure
chitosan scaffolds served as controls. Since, the compressive elastic moduli of chitosan
22
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gelatin scaffolds with 25% and 50% gelatin were not significantly different from that of
pure chitosan scaffolds (Huang et al., 2005), using these combinations avoided the
variability in chondrocyte response due to inherent stiffness of scaffold. Adult porcine
knee chondrocytes were seeded on all of these scaffolds placed in transwell inserts and
cultured for 3 weeks. Transwell inserts help to eliminate the diffusional limitations of
static culture on tissue culture plate. Due to the easy availability of cells pig model was
selected for initial in vitro pilot studies. One scaffold from each of these was analyzed for
neochondrogenesis and secretion of extra cellular matrix (ECM) components by immunohistochemistry procedures. The remaining two scaffolds were divided into four equal
parts and used to quantification of amounts of DNA and sulphated glycosaminoglycans
(sGAG) secreted by cells after 3 weeks in culture. This data from sGAG (µg) normalized
to amount of DNA (µg) was analyzed by One-way ANOVA analysis using the GLM
procedure of SAS (SAS Institute, Inc. NC, USA). Duncan’s Multiple Comparison test
was performed to indicate the differences in groups if significant differences were
detected from ANOVA.
In order to quantify the effect of culture techniques on ECM secretion by cells and
chondrogenesis, a large batch (22 numbers) of 1:1 (w/w) chitosan gelatin scaffolds was
prepared. Ten scaffolds each were cultured in static (transwell inserts) and dynamic
(Rotating wall bioreactor) cultures for 3 weeks. Six scaffolds from each of these groups
were qualitatively analyzed for neochondrogenesis and ECM secretion by immuno
histochemical staining. The other four were used for DNA and sGAG quantification. The
mechanical properties of nine scaffolds were evaluated by testing them for compressive
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resilience. Two additional scaffolds were cultured in for a total of five weeks in rotating
wall bioreactor and analyzed thereafter similarly. In order to quantify scaffold
degradation and/or dissolution due to culture conditions only, the mechanical properties
of cell seeded cultured scaffold after 3 and 5 weeks were compared to those of no cellseeded scaffolds left in similar culture conditions for 3 and 5 weeks.

Experimental Methods
Selection of Chitosan
The selection of chitosan for orthopedic purposes is based on factors like the
biocompatibility, degradation residues, solubility, and mechanical properties of chitosan
constructs. There should be a balance between the in vivo degradation of chitosan and the
regeneration of new tissue or matrix. The degree of deacetylation (DDA) of chitosan
influences its in vivo degradability (Tomihata and Ikada, 1997). Higher the DDA, slower
is the in vivo degradation. Since, the lysozyme mediated degradation of chitosan involves
acetyl groups their loss during the process of deacetylation is one reason for the slower
rate of degradation. As little as 10% change in DDA relation has a significant effect on
cell attachment and cell viability after as little as 2 days of culture (Prasitsilp et al., 2000).
This makes the selection of chitosan as one of the deciding factors for effectiveness of the
implant. Chitosan with DDA in the range of 80 to 90% was seen to be biocompatible and
showed adequate cell attachment and proliferation (Nettles et al., 2002). Chitosan used
for this project was a kind gift from AgraTech International, Inc. (Denville, NJ). The
chitosan manufactured by them was either ungraded or near to an industrial grade rather
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than medical or pharmaceutical grade. Since, the DDA of a specific batch of chitosan was
not reported earlier it was empirically quantified during or after its use to make scaffolds.
The DDA values were not similar (± 10%) among different batches. Due to availability
of chitosan, the batch with 84% DDA was used to test the effect of gelatin concentration
while the batch with DDA (between 50-60%) was used to test the effect of culture
technique.
Sterilization Procedure for Chitosan
The required amount of chitosan was taken in sterile centrifuge tubes and boiled
with excess amounts of cell biology grade water for 2-3 hours. This was followed by its
dehydration in graded series of alcohol solutions (10% to 100% in increasing steps of
10%) in cell biology grade water. Chitosan was left in 70% alcohol for atelast 8 hours for
optimum sterilization (Marreco et al., 2004). Later, chitosan was left in a high
temperature enclosure for few hours or until completely dry of alcohol. According to Lim
et al. (1999) dry heat (oven) and saturated steam (autoclave) reduces solubility of
chitosan in acetic acid. Since large amounts of insoluble residues were obtained when
chitosan subjected to dry heat was dissolved in acetic acid, the drying step was
discontinued.
Boiling chitosan in cell biology grade water didn’t seem to have much effect on
its solubility or physical characteristic like color and mechanical integrity. Required
amount of chitosan was taken in a pre weighed and autoclaved beaker along with cell
biology grade water and boiled for at least 3 hours. The beaker was reweighed and acetic
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acid and cell biology grade water were added to have 1% (w/v) solution of chitosan in
1% (v/v) acetic acid solution.
Preparation of Porous Chitosan Gelatin Scaffolds
Undissolved components from above chitosan acetic acid solution were filtered
through a gauze filter whenever required. Calfskin gelatin (G-9382, Type B, 225 bloom,
Sigma-Aldrich St. Louis, MO) was dissolved at 10mg/ml in 1% acetic acid and added to
the chitosan solution to have final proportion of chitosan to gelatin as 1:1, 2:1 and 3:1.
These mixtures were put in to wells of a 96-well plate tissue culture plate (100 µL per
well) and frozen at -20º C for at least 24 hours. Care was taken that the frozen scaffolds
did not thaw while transferring and handling. The scaffolds were equilibrated to low
temperature in an -80º C freezer for about an hour and lyophilized in a Flexi-Dry Freeze
Dryer (FTS Systems, Inc. Stone Ridge NY) at temperature between -70º C to -80º C.
For preparing the large batch of 1:1 chitosan gelatin scaffolds, 1% w/v solutions
of chitosan (DDA between 50-60) and porcine skin gelatin (G-1890, Type A, 300 bloom,
Sigma-Aldrich St. Louis, MO) in 1% aqueous acetic acid were mixed in equal amounts
and vortexed to give a highly viscous mixture, which was used to cast the scaffolds.
Porcine skin gelatin was used instead of calfskin gelatin in order to avoid any immune
response to it from porcine knee chondrocytes.
Cell Isolation
Due to easier availability and fairly high cell to matrix ratio, the pig model was
selected to check the in vitro response of chondrocytes to chitosan gelatin scaffolds.
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Chondrocytes were isolated from adult female porcine knee cartilage maintaining aseptic
techniques. The pieces of cartilage from knee were minced and incubated in a solution
containing 1mg/ml type 2 collagenase in Dulbecco’s Modified Eagle Medium (DMEM),
5% adult bovine serum and 1.5% antibiotics-antimycotics (10,000 units/ml penicillin G,
10 mg/ml streptomycin sulfate and 25 µg/ml amphotericin B). With most of the cartilage
pieces dissolved this solution after about 12 hours was filtered through a sterile 100µm
filter to remove undissolved clumps. The filtrate was centrifuged at 3000 rpm for 8
minutes and the cell pellet obtained was re-suspended in cell culture medium containing
DMEM, 10% fetal bovine serum, 1.5% antibiotics-antimycotics, and 50µg/ml ascorbic
acid and seeded on scaffolds.
Scaffold Pretreatment and Cell Culture
As mentioned above, after re-hydration in graded series of alcohol with 8 hours
70% alcohol, the scaffolds were disinfected in a solution of phosphate buffer saline (PBS)
with 2% antibiotics-antimycotics for 1-2 hours. In order to observe the response of cells
to the varying degree of chitosan and gelatin the aforesaid 1:1, 2:1, 3:1 and pure chitosan
(control) scaffolds were infiltrated with DMEM at 37º C and seeded with chondrocytes at
25 x 103 cells/scaffold.
Nettles et al. (2002) report that the cells grown in static culture mainly colonize
and proliferate at the boundaries of the cell-seeded scaffold. In order to get an even cell
distribution and attachment, 5 aliquots, each of 5µl of concentrated cell suspension, were
pipetted on 4-5 physically different locations on the scaffolds. The scaffolds were placed
in transwell inserts (12µm pore size and 12 mm diameter) kept in the wells of a 48 well
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tissue culture plate with just air interface and cells were allowed to attach to them. After
about 3 hours, 800µl cell culture medium was added to each of the wells (600µl outside
the transwell insert and 200µl directly on the scaffold). These cell-seeded scaffolds were
cultured for 3 weeks in a humidified, 37º C incubator containing 5% CO2. The medium
was changed every 3 days and ascorbic acid (50µg/ml) was supplemented daily in to each
well.
A large batch of 1:1 chitosan to gelatin scaffolds was prepared using the similar
protocol to check the effect of cell culture method. A set of 12 scaffolds each was
cultured in transwell inserts and in a rotating wall bioreactor. The cell seeding protocol
was modified in order to facilitate deeper penetration of cells into the scaffolds. The wet
scaffolds infiltrated with DMEM (37º C) were lightly blotted off extra medium by an
autoclaved filter paper and placed in a 48 well tissue culture plate without any medium.
This was done to ensure that the scaffold holds most of the cell suspension. 12.5µl of cell
suspension (17.4 x 106 cells/ml) was added to each scaffold and cells were left to attach
for about 3 hours.
A high number of apoptotic cells are seen after about an hour of seeding cells on
the scaffolds. This implies the physiochemistry of implant material surface may have an
influence on cell signaling (Mao et al., 2004). Hence to facilitate adequate cell
attachment and to replenish lost cells, 12.5µl of cell suspension was added per scaffold
after 3 hours followed by another 25µl after a gap of one hour. This added to a total of
about 870 x 103 cells/scaffold. Zhao et al. (2002) followed similar cell seeding strategy.
Scaffolds to be cultured in transwell inserts placed in them with 800µl culture media.
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The laminar flow profile setup in the rotating wall bioreactor helps to overcome
mass transport limitations of static culture and is seen to stimulate faster and more
uniform tissue generation and ECM secretion by chondrocytes seeded on Polyglycolic
acid (PGA) scaffolds (Vunjak-Novakovic et al., 2002, Vunjak-Novakovic et al., 2004).
The scaffolds to be cultured in the bioreactor were left in 48 well tissue culture plate for
24 hours with about 200µl/scaffold growth media to support them and allow cell
adhesion. In order to evaluate efficacy of this culture technique they were then carefully
transferred into a 50 ml rotating wall bioreactor (RCCS-D, Synthecon, Inc., Houston,
TX). The cell culture medium in bioreactor was partially replaced (25ml each time) with
fresh medium every 7 days for a total culture time of 21 days. In order to maintain
sterility of the apparatus 50µg/ml ascorbic acid was added only during medium change.
The bioreactor was allowed to rotate in a humidified, 37º C incubator with 5% CO2. The
speed of the rotating bioreactor was adjusted such that the scaffolds suffered minimum
shearing force from the rotating medium and were in a constant state of free fall. Ten
scaffolds each from transwell and bioreactor were used for further analysis and other two
were left in culture for two more weeks. With half of the media in bioreactor replaced at
the end of 3 weeks no further replacement was performed up to the end of five weeks.
Since, two scaffolds in transwell had to be removed from culture due to infection; they
were not available for analysis at the end of 5 weeks.
Histology and Immunohistochemistry
The cell-seeded scaffolds cultured for 3 weeks were fixed in Carnoy’s solution
(3:1 solution of 95% ethanol to glacial acetic acid) for 3 hours. This fixative was
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recommended by Developmental Hybridoma Bank, Iowa City, Iowa, for use with the IIII6B3 anti-type II collagen antibody, used for immuno-histochemical procedures.
These scaffolds were washed in 95 % ethanol followed by 100 % alcohol (3
washes each) for complete dehydration. The scaffolds were then left in 1:1 solution of
100% ethanol and infiltration solution (Immuno-Bed Kit, Polysciences, Niles, IL) for 810 hours and subsequently infiltrated for 5-6 hours before embedding into glycol
methacrylate embedding media (Immuno-Bed Kit, Polysciences, Niles, IL). After the
overnight polymerization the glycol methacrylate blocks were mounted on a rotary
microtome and 5µm sections were cut. These sections were mounted on charged slides
and allowed to dry. They were then stained with hematoxylin followed by 1% toluidine
blue to selectively stain nuclei (purple) and ECM (blue) respectively.
The sections were analyzed for immunohistochemistry for the generation of type
II collagen using a chick anti mouse monoclonal primary antibody against type II
collagen (II-II6B3, Developmental Studies Hybridoma Bank, University of Iowa, Iowa
City, IA) and a streptavidin-peroxidase immunohistochemical staining kit (Histostain-SP
DAB, Zymed Laboratories, South San Francisco, CA) according to the manufacturer’s
instructions as follows. The sections were incubated with 2500 IU/ml hyaluronidase
(H6254, Sigma-Aldrich, St. Louis, MO) for 45 min to digest hyaluronic acid in ECM that
may be blocking antigen binding sites. After washing in PBS, they were incubated in
non-immune goat serum for 20-30 min to avoid any nonspecific staining. The
experimental controls were then incubated with II-II6B3 type II collagen primary
antibody for 90-120 min at 37º C in a CO2 incubator. Controls were left with PBS during
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this time. After 3 x 2min washes the sections were incubated with broad-spectrum
biotinylated secondary antibody for 30 min. This was followed by washing in PBS and
incubation with streptavidin-peroxidase enzyme conjugate and DAB cromogen for 20
min each. The sections were counter stained with hematoxylin to stain cell nuclei and
mounted using Aqua-Poly/Mount (Polysciences, Inc., Warrington, PA).
Quantification of DNA on Scaffolds
After culturing the scaffolds for 3 weeks they were taken out and divided in 4
smaller pieces to have more number of samples for DNA quantification. The cells on
each of these were lysed in 300µl of NP-40 cell lysis solution (0.5% Igepal CA-630, 10
mM Tris-HCl, 10 mM NaCl, 3 mM MgCl2, 0.5% (v/v) Nonidet P-40). After vortexing for
about 30 min they were stored at 4º C before DNA could be measured. The DNA was
quantified through bisbenzimide fluorometry assay based on the Hoescht dye procedure
using DNA-Quantification Kit (DNA-QF, Sigma-Aldrich St. Louis, MO). The
fluorescent dye bisbenzimide binds primarily to the AT sequences in the minor groove of
double stranded DNA. When excited at 360nm the fluorescence emission at 460nm gives
a measure of DNA present. Calf thymus DNA was used for constructing the standard
curve.
Quantification of Sulphated Glycosaminoglycan on Scaffolds
The cell lysate on the scaffolds was replaced by 250µl/sample of 1% v/v papain
and 1 mg/ml cysteine in 50 mM sodium acetate buffer (pH 6) and digested at 60ºC for 810 hours. This solution dissolves GAGs in the ECM secreted by the cells. For the
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experiment to test effect of gelatin concentration on response to seeded chondrocytes 1,9dimethyl-methylene blue procedure from Farndale et al. (1986) was followed to measure
sGAG. The intensity of bound dye was read on a µQuant spectrophotometer (Biotek
Instrument,

Inc.)

at

525nm.

In

this

method

the

glycosaminoglycan-

dimethylmethyleneblue complexes eventually start to aggregate and precipitate
immediately on mixing. Hence, the method may show some variability in its readings
over time. Hence for all further analysis the 1,9-dimethylmethylene blue (DMMB)
Blyscan sGAG Assay (Biocolor Ltd., North Ireland) was used. Known quantity of aliquot
from papain digestate was mixed with 1ml of DMMB dye in an inorganic buffer. The
mixture was vortexed for 30-45 min and the formed complexes were centrifuged into a
pellet. After draining off the supernatant fluid the pellet was dissociated with a chaotropic
salt solution in aqueous propan-1-ol by vortexing for 30-45 min. The absorbance of dye
released from pellet was read at 656nm on a µQuant spectrophotometer (Biotek
Instrument, Inc.) at 656nm. Bovine trachea chondroitin 4-sulphate was used to prepare
the standard curve.
Cell Attachment Kinetics
Freeze dried scaffolds were re-hydrated in graded series of alcohol and
equilibrated in culture media at 37º C. Chondrocytes were isolated from hip and knee
cartilages of 4 adult rabbits using similar protocol as mentioned above. High-density cell
suspension (5 x106 cells/ml) in culture media was added in 2 ml XPERTEK glass crimp
vials (P. J. Cobert Associates, Inc., MO, USA) containing 2 scaffolds each. These vials,
when capped with gas permeable PTFE/Silicone rubber crimp caps, were externally
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attached to the rotor of Synthecon bioreactor and set in rotary motion at very low speeds.
The silicone rubber caps are gas permeable and hence provide for the required CO2
exchange. Everyday the cells from old culture media were isolated by centrifugation at
about 2000 rpm for 8 min, resuspended in fresh media with 50µg/ml ascorbate, and
replaced on scaffolds. At intervals of 1, 4 and 7 days scaffolds were fixed, embedded in
polymethylmethacrylate, sectioned (5µm), and stained with hematoxylin to evaluate cell
viability and penetration inside the matrix of scaffold.
Mechanical Testing of Scaffolds
Mechanical testing of scaffolds was performed only for the large batch of 1:1
chitosan gelatin scaffolds to see the effect of culture technique on mechanical properties
of scaffolds. After 3 weeks of culture compressive resilience test was performed on 9
scaffolds from both groups using MACH-1 Mechanical tester (Biosyntech, Inc., Quebec,
Canada). Wet scaffolds were placed submerged in a testing dish filled with cell culture
medium. One kg load cell was be used to detect 0.5 grams of contact force from most of
the scaffolds. Since, the scaffolds were much thicker before culture than after,
mechanical testing on wet uncultured scaffolds was performed with 1gm force as the
threshold for detecting contact. This was followed by a delay step of 30 seconds and five
subsequent compressions on scaffolds (100µm each covered in 2 seconds). The MACH-1
system measures amount of reaction force exerted by the scaffold on the indenter head,
amplifies, and streams the data to the connected computer. The scaffolds were allowed to
relax between adjacent compressions till they exerted an almost constant force on the
indenter. If the slope of indenter load-data points (relaxation rate) fell below 0.5 g/min in
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a window of 5 seconds a constant force was assumed and a new compression routine
initiated. ImageJ (Image processing and analysis in Java, Wayne Rasband, NIH, USA)
was used to analyze the approximate contact area of the scaffolds from their digital
images. The stress relaxation response of scaffolds was evaluated from this data by
plotting equilibrium stress achieved by the scaffolds after stress relaxation, against the
corresponding constant strain applied to the scaffolds. Slope of this curve (line) gave the
wet compressive elastic modulii of the scaffolds. Of the five stress strain data points
obtained for each test, first point was neglected from slope calculation so as to achieve
better linearity for some of the non linear stress strain curves.
In order to observe the change in mechanical properties of scaffolds due to
culture technique alone, 3 scaffolds with no cells were rehydrated in graded series of
alcohol and left in static culture and bioreactor culture for 3 and 5 weeks with PBS. These
were similarly tested mechanically and the data compared with that of cell seeded
scaffolds.
Statistical Analysis
SAS system (SAS Institute, Inc. NC, USA.) was used to perform One-way
Analysis of Variance (ANOVA) procedure for comparing different groups in the
experiment for their sGAG/DNA values and compressive resilience. If any statistically
significant (p<0.05) difference was detected from ANOVA Duncan’s multiple range test
was performed to detect specific differences within the compared groups. Fisher’s least
significance difference (LSD) performs all possible comparison between the compared
groups to detect if any differences exist. In LSD the experiment-wise error rate tends to
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be much higher compared to comparison wise error rate. On the other hand Tukey’s
honestly significant difference (HSD) procedure gives a very conservative experimentwise error rate causing to loss of power. Hence Duncan’s multiple range test is a good
compromise between LSD and HSD as it helps to control experiment-wise type I error
rate without excessive loss of power (Freund and Wilson 2003).

CHAPTER III
RESULTS

Objective 1: Preparation of Porous Chitosan Gelatin Scaffolds
Porous chitosan scaffolds were prepared from chitosan and gelatin blended in
proportions 1:1, 2:1, 3:1, and 100% chitosan. Freeze dried scaffolds were about 5 mm in
diameter and 2-3 mm in thickness. When dry the scaffolds were spongy and fragile and
shrunk in their physical dimensions when hydrated. Wet scaffolds before and after
culture were strong enough to be handled using forceps.
The 100% gelatin scaffolds did not sustain the alcohol sterilization step and
dissolved completely. Pure chitosan scaffolds served as controls for all further analysis.
Objective 2: Effect of Gelatin Concentration on Chondrocyte Response
Variation in the gelatin concentrations in scaffolds did have a notable effect on the
physical appearances as well as chondrocyte growth and the amount of extra-cellular
matrix (ECM) secreted on them.
The scaffolds with higher amounts of gelatin in them were less opaque than pure
chitosan scaffolds. After 3 weeks in culture the scaffolds were mechanically intact and
those with gelatin showed a notable decrease in their circumference and thickness.
36
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One-way ANOVA analysis on the amount of sulphated glycosaminoglycans (sGAG)
normalized to the amount of DNA (µg/µg) for different blends showed significant
difference among the groups (p-value 0.0035). Since, at α=0.05 a significant difference
existed between these groups, Duncan’s multiple comparison was performed to identify
these differences. The sGAG/DNA values from 50% chitosan gelatin scaffolds were
significantly higher as compared to other groups. Since, the DNA quantified from the
different scaffolds types was not statistically different, it may be concluded that the
amount of sulphated GAG secreted by cells on the 50% gelatin blend was higher as
compared to that on other blends and pure chitosan.

Average DNA & GAG (in
micrograms)

sGAG and DNA
12

*

10
8

DNA

6

sGAG

4
2
0
50%

33%

25%

0%

% of gelatin in chitosan gelatin
scaffolds

Figure 1: sGAG and DNA for different blends of chitosan and Gelatin after 3 weeks
culture in transwell inserts. Bars indicate one standard deviation and *
indicates statistically significant values among groups
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The GLM Procedure
Dependent Variable: value

sGAG normalised to DNA
Sum of

Source

DF

Squares

Mean Square

Model

3

60.6809903

20.2269968

Error

28

98.9689637

3.5346058

31

159.6499540

Corrected Total

F Value Pr > F
5.72

0.0035

The GLM Procedure
Duncan's Multiple Range Test for value
Means with the same letter are not significantly different.
Duncan Grouping

Mean

N

group

A

4.246

8

50%Gelatin

B

1.924

8

25%Gelatin

1.380

8

33%Gelatin

1.066

4

100%Chitosan

B
B
B
B

Figure 2: ANOVA comparison of sGAG/DNA (µg/µg) values obtained from different
chitosan gelatin blends.

Figure 3: Hematoxylin and toluidine blue staining of section through interior of chitosan
gelatin sponge showing round cell morphology. Cells are violet; chitosan is
blue. (40x objective)

Overall chondrocytes cultured on chitosan gelatin scaffolds showed a circular
morphology (Figure 3). Figure 4 shows hematoxylin (nuclei blue) and toluidine Blue
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(proteoglycan ECM purple) staining of cross sections through scaffolds cultured in
transwell inserts for 3 weeks. A general gradient was seen in the amount and penetration
of proteoglycan rich ECM deep inside the scaffold as the amount of gelatin in the
scaffold increased. Of these blends, those with 50% chitosan and gelatin showed much
dense and deep penetration of ECM in scaffold. Toluidine staining of sections from
cultured scaffolds showed metachromatic staining of ECM. Immunostaining of sections
through the cultured scaffolds indicated the presence of Type II collagen. Especially, the
50% gelatin scaffolds showed dense deposits spanning deep into the interior of scaffolds
(Figure 5). The ECM was predominantly seen near the boundaries and surfaces of
scaffolds and was localized in few patches as seen in the sections. Compared to other
groups, the ECM for the 50% chitosan gelatin blends was prominently seen to span over
fairly large distributed regions on the scaffold surface.
This confirms with the above result that 50% gelatin scaffolds were able to
support

neochondrogenesis

helped

to

maintain

a

chondrocytic

phenotype.
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A

C

B

D

E

Figure 4: Hematoxylin and toluidine blue staining of chitosan scaffolds with (a) 100%
Chitosan (b) 25% Gelatin (c) 33% Gelatin all at 10x (d) 50% Gelatin at 4x (e)
50% Gelatin at 10x after 3 weeks of culture in transwell inserts.
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Figure 5: Immuno staining for Type II collagen in (a) 1:1 chitosan gelatin and (b) 100%
chitosan scaffolds counterstained with hematoxylin. Chitosan is stained blue
and collagen indicated by reddish brown deposits. (10x objective)

Objective 3: Test the Effect of Culture Technique on Generation of ECM
A large batch of 1:1 chitosan gelatin scaffolds was cultured in trans-well inserts
and in a rotating cell culture system to test the effects of culture technique on growth and
proliferation of chondrocytes.
Table 2 Sulphated GAG (µg) and DNA (µg) for four scaffolds each cultured in transwell
inserts and Bioreactor for 3 weeks
Scaffolds in transwell for 3 weeks
Scaffold
T1
T2
T3
T4

sGAG(µg)
1.135446
1.626234
1.245984
0.918791

DNA(µg)
31.059596
27.978788
31.640404
28.736364

sGAG/DNA
(µg / µg)
0.036557
0.058124
0.03938
0.031973

Scaffolds in Rotating Bioreactor for 3 weeks
sGAG/DNA
Scaffold sGAG(µg) DNA(µg) (µg / µg)
R1
0.042683 29.25959
0.001459
R2
0.191057 39.31823
0.004859
R3
0 25.31842
0
R4
0.028455 25.38421
0.001121
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Table 3 Sulphated GAG (µg) and DNA (µg) for one scaffold cultured in Bioreactor
for 5 weeks
R11 scaffold in
bioreactor for 5
weeks

sGAG(µg)

DNA(µg)

1.311535

19.21026

sGAG/DNA
(µg/µg)
0.068273

The amount of DNA quantified after 3 weeks of culture from trans-well and
bioreactor scaffolds was not significantly different (p value 0.1973). However, the
amounts of sGAG/DNA were significantly different between these groups (p value
0.0004) indicating differences in sGAG content secreted on scaffolds.
Dependent Variable: dna

DNA in micrograms
DF

Sum of
Squares

Mean Square

F Value

Pr > F

Model

2

100.3814383

50.1907191

2.15

0.1973

Error

6

139.8811045

23.3135174

Corrected Total

8

240.2625428

Source

Figure 6: ANOVA comparison for the amounts of DNA (µg) obtained from scaffolds
after culturing 3 weeks in transwell inserts and Bioreactor (n=4 each)
and 5 weeks in Bioreactor (n=1)

Dependent Variable: sgagbydna

sGAG normalised to DNA (µg /µg)
DF

Sum of
Squares

Mean Square

F Value

Pr > F

Model

2

0.00507336

0.00253668

37.19

0.0004

Error

6

0.00040920

0.00006820

Corrected Total

8

0.00548256

Source

The GLM Procedure
Duncan's Multiple Range Test for sgagbydna
NOTE: This test controls the Type I comparisonwise error rate, not the experimentwise
error rate.
Alpha
Error Degrees of Freedom

0.05
6
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Error Mean Square
0.000068
Harmonic Mean of Cell Sizes
2
NOTE: Cell sizes are not equal.
Number of Means
Critical Range

2
.02021

3
.02094

Means with the same letter are not significantly different.
Duncan Grouping

Mean

N

group

A

0.068273

1

r_5w

B

0.041508

4

t_3w

C

0.001860

4

r_3w

Figure 7: ANOVA and Duncan's Multiple comparisons for sGAG/DNA values obtained
after culturing scaffolds for 3 weeks in transwell inserts and bioreactor (n=4
each) and 5 weeks in bioreactor (n=1)

Duncan’s multiple comparison test indicated that scaffolds cultured in transwell
inserts had higher amounts of sGAG/DNA as compared to those in Bioreactor. The single
scaffold in bioreactor cultured for 5 weeks had higher values of sGAG/DNA compared
those from 3 weeks. This indicates that culturing in bioreactor did not have an extremely
significant stimulatory effect on ECM secretion for short culture time.
Gross observation of scaffolds cultured in bioreactor showed a filmy/fibrous
tissue surrounding them. Although not analyzed separately, this may be a mass of fibrous
tissue as a result of high amount of shearing from culture media. The decrease in the
circumferential area and thickness of scaffolds may be attributed either to metabolic
activity of seeded cells or to the weak adhesion in chitosan gelatin blend, which did not
sustain the dissolving effect of surrounding fluid. A noticeable degradation was observed
after 5 weeks in bioreactor.
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In order to check the contribution of culture technique alone to scaffold
degradation scaffolds (3 each) were left in static petri dishes and rotating bioreactor
without any cells on them for 3 and 5 weeks. Compressive resilience testing on them after
3 and 5 weeks showed that the mechanical properties of scaffolds did change due to
culture conditions. The average elastic modulus of scaffolds without any cells gradually
decreased, while it remained same or improved for cell-seeded scaffolds after culture.

#
#
#

Figure 8: Average compressive elastic modulus (KPa) of scaffolds from different groups.
Those marked with * & # are significantly different

Scaffolds with no cells and in static conditions, similar to transwell inserts,
showed a slight decrease (Figure 9 not statistically significant at α= 0.05) in their elastic
modulus after 3 weeks. But, these values were significantly lower as compared to elastic
moduli of cell-seeded scaffolds after 3 weeks (Figure 8 marked as *), thus suggesting
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secretion of ECM components by cultured cells had an effect on scaffold mechanical
properties.
Compressive elastic modulus
The GLM Procedure
Youngs modulus
Sum of
DF
Squares
Mean Square

Dependent Variable: value
Source
Model

2

5.35715891

2.67857946

Error

14

8.86079589

0.63291399

Corrected Total

16

14.21795480

F Value

Pr > F

4.23

0.0365

Compressive elastic modulus
The GLM Procedure
Duncan's Multiple Range Test for value
NOTE: This test controls the Type I comparisonwise error rate, not the experimentwise
error rate.
Alpha
0.05
Error Degrees of Freedom
14
Error Mean Square
0.632914
Harmonic Mean of Cell Sizes 4.655172
NOTE: Cell sizes are not equal.
Number of Means
Critical Range

2
1.118

3
1.172

Means with the same letter are not significantly different.
Duncan Grouping

Mean

N

group

A
A
A

2.6214

9

celltrans3

1.7493

5

nocellbefore

1.2242

3

nocelltrans3

B
B
B

Figure 9: ANOVA and Duncan's Multiple comparisons of Elastic moduli of scaffolds
cultured in static (transwell) conditions with and without cells for 3 weeks.

Similarly, comparing scaffolds from rotating bioreactor (RCC) without cells
showed that their elastic moduli significantly decreased after 3 and 5 weeks as compared
to initial values. Elastic modulus of cell-seeded scaffolds after 5 weeks in bioreactor was
higher than that obtained after 3 weeks (cell seeded scaffolds) and from no cell seeded
scaffolds in bioreactor (Figure 8 marked as # also see Figure 10). Since the sGAG values
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obtained after 5 weeks were also significantly higher than that after 3 weeks (Figure 7),
this improvement in mechanical properties should be due to secretion of ECM by
cultured cells.

Dependent Variable: value
Source

Compressive elastic modulus
The GLM Procedure
Youngs modulus
Sum of
DF
Squares
Mean Square

Model

4

8.94819878

2.23704970

Error

17

3.27651088

0.19273593

Corrected Total

21

12.22470966

F Value

Pr > F

11.61

<.0001

Compressive elastic modulus
The GLM Procedure
Duncan's Multiple Range Test for value
NOTE: This test controls the Type I comparisonwise error rate, not the experimentwise
error rate.
Alpha
0.05
Error Degrees of Freedom
17
Error Mean Square
0.192736
Harmonic Mean of Cell Sizes 3.383459
NOTE: Cell sizes are not equal.
Number of Means
Critical Range

2
.7121

3
.7470

4
.7689

5
.7840

Means with the same letter are not significantly different.
Duncan Grouping

Mean

N

group

A

2.8415

2

cellrcc5

B
B
B

1.7493

5

nocellbefore

1.6029

9

cellrcc3

C
C
C

0.5932

3

nocellrcc3

0.5885

3

nocellrcc5

Figure 10: ANOVA and Duncan's Multiple comparisons of Elastic moduli of scaffolds
cultured in rotating bioreactor conditions with and without cells for 3 and 5
weeks.

The above two comparisons indicate that culturing chondrocytes on 1:1 chitosan
gelatin scaffolds improved their mechanical properties from activity of cultured
chondrocytes viz. secretion of ECM. To determine which of the two culture techniques
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was more effective in doing so, the elastic moduli of cell seeded scaffolds in transwell
and bioreactor was compared with that of no cell seeded scaffolds after 3 and 5 weeks.

Dependent Variable: value

Elastic Modulus (KPa)
DF

Sum of
Squares

Mean Square

F Value

Pr > F

Model

5

18.30186400

3.66037280

8.19

0.0001

Error

23

10.28455481

0.44715456

Corrected Total

28

28.58641881

Source

The GLM Procedure
Duncan's Multiple Range Test for value
NOTE: This test controls the Type I comparisonwise error rate, not the experimentwise
error rate.
Alpha
0.05
Error Degrees of Freedom
23
Error Mean Square
0.447155
Harmonic Mean of Cell Sizes 3.483871
NOTE: Cell sizes are not equal.
Number of Means
Critical Range

2
1.048

3
1.101

4
1.134

5
1.158

6
1.176

Means with the same letter are not significantly different.
Duncan Grouping

Mean

N

group

A
A
A

2.8415

2

rcell5

2.6214

9

tcell3

C
C
C
C
C
C
C

1.6029

9

rcell3

1.2242

3

nocelltrans3

0.5932

3

nocellrcc3

0.5885

3

nocellrcc5

B
B
B

Figure 11: ANOVA and Duncan's Multiple Comparison test on compressive elastic
moduli of scaffolds cultured with cells for 3 weeks in transwell inserts and
bioreactor (n=9 each), 5 weeks in bioreactor (n=2) and without any cells static
and bioreactor
ANOVA comparisons indicated differences between compared groups (p value
0.001). Moduli of scaffolds after 3 weeks in transwell and bioreactor indicate no
statistically significant difference. However, after 5 weeks in bioreactor the elastic
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moduli of scaffolds were not different from 3 weeks in transwell group. Values from
these 2 groups were significantly higher than those obtained from no cell seeded
scaffolds after 3 and 5 weeks. This confirms enhancement in mechanical properties of
scaffolds due to the activity of seeded chondrocytes. Regarding the effectiveness of
culture techniques, bioreactor culture helped to improve scaffold mechanical properties
over 3 to 5 weeks but showed marginal (not statistically significant at α=0.05)
improvement over transwell culture.
Cultured scaffolds were embedded in polymethylmethacrylate, sectioned, and
stained with hematoxylin and tolluidine blue to observe cell penetration and proteoglycan
rich extracellular matrix. Sections from these embedded scaffolds were further stained
treated with II-II6B3 type II collagen primary antibody and counterstained with to show
collagen (Type II) stained yellow.
As seen in figure 12 (A & B) scaffolds in transwell showed cells localized near
one of its surfaces and more prominently near the edges of the scaffold. These dense cell
layers showed secretion of ECM components but these did not appear to penetrate deep
inside the scaffold. There were few instances of large interconnecting pores were seen
localized near one surface of the scaffold. It was not possible to track whether the surface
with dense cell deposition was at top or bottom when cells were seeded on the scaffold.
Sections from bioreactor scaffolds after 3 weeks (Figure 14) showed cells to be
distributed deep inside the porous scaffold. The scaffold structure was notably open and
interconnected with large pores as compared to those from transwell. Groups of cells
were seen to line pores and crevices deep inside the scaffold. Few cell groups were seen
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attached to the surface of the scaffold. Secretion of ECM components was seen to span
fairly well across some cross sections and the cells in these groups appeared to maintain a
circular morphology. This indicates the cultured chondrocytes maintained their
chondrocytic phenotype.
After 5 weeks in bioreactor (Figure 15) the ECM components stained denser than
that was seen after 3 weeks. Also less number of cells were seen to be dispersed across
cross section of these scaffold as compared to earlier.
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A

B

C

D

E
Figure 12: Scaffolds after 3 weeks in transwell. Hematoxylin and Tolluidine blue staining
of sections through surface (A) and cross section (B). Immuno-staining for
collagen type II of section through surface (C), cross section (D & E) all with
10x objective.
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C

D

E

F

Figure 13: Scaffolds after 3 weeks in bioreactor. Hematoxylin and Tolluidine blue
staining of sections through surface (A) and cross section (B, C, & D).
Immuno-staining for collagen type II of section through cross section (E & F)
all with 10x objective.
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A

B

Figure 14: Scaffolds after 5 weeks in bioreactor. Immuno-staining for collagen type II of
section through cross section (A negative control & B positive control) all
with 10x objective.

Cell Attachment Kinetics
Immuno histochemical analysis of scaffolds from bioreactor and transwell
showed concentration of ECM components in small groups/patches localized near the
scaffold boundaries and surfaces. Such a trend was expected from static transwell culture
due to the absence of any mixing regimen. In order to determine cell penetration and
viability that is achieved after a dynamic cell seeding technique, similar to a bioreactor,
cell attachment was studied over upto a week. Results after day 1 showed almost uniform
cell loading across smaller cross sections (Figure 12A). Some of the larger cross sections
through the central region of scaffolds did not show such uniform cell loading but they
showed dense groups of cells in patches and clumps (Figure 12B). These dense cell
colonies showed fairly deep penetration inside the porous scaffold matrix.
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After day 4 similar trend was seen with almost uniform cell distribution across
small cross sections (Figure 12C). The larger cross sections from central regions of
scaffolds had better or at least maintained deeply penetrated cell colonies (Figure 12D).
Scaffold structure appeared to become more open, and this may be due to dissolution of
gelatin predominantly near the surfaces. Gelatin component was seen in form of
elongated fibers entangled with the chitosan matrix (Figure 12E). Cells appeared to
maintain a circular to ellipsoidal morphology (Figure 12F). Due to infection of these
scaffolds after 5 days, the presence of chondrocytes in scaffold sections could not be well
quantified. After 7 days in culture the scaffold pore structure became more open and an
interconnected chitosan matrix was predominantly seen (Figure 12G).
These results from analysis of cultured scaffolds grossly (comparing their elastic
modulus) and microscopically (from immuno-histochemical staining) give enough
evidence to confirm that chitosan gelatin scaffolds support chondrogenesis, while those
containing 50% showed better results compared to other blends and pure chitosan. For
short culture periods, up to 3 weeks, the scaffolds cultured in rotating bioreactor did not
outperform those cultured in transwell inserts.
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Figure 15: Cell attachment kinetics. Hematoxylin staining of cross sections through
scaffold showing cultured chondrocytes after 1 day (A and B), 4 days (C, D,
E) all with 4x objective; gelatin network after 4 days (F with 10x) and
scaffold structure after 7 days (G with 40x objective).

CHAPTER IV
DISCUSSION

Objective 1: Preparation of Porous Chitosan Gelatin Scaffolds
Porous 3D scaffolds were prepared from blends of chitosan and Gelatin by simple
freezing and lyophilizing these mixtures, maintaining aseptic techniques. Due to the
different types of materials used in preparation, slight structural dissimilarities were
observed between the scaffolds prepared for preliminary tests and large batch. Calfskin
gelatin (Type B, 225 bloom) was used in preliminary tests to check the effects of gelatin
concentration. For the large batch of 1:1 chitosan gelatin scaffolds, porcine skin gelatin
(Type A, 300 bloom) was selected to have better cytocompatibility with porcine knee
chondrocytes. Type A gelatin is derived from acid cured tissue while type B is obtained
from lime treated tissue. Higher the bloom number stronger gel is formed when gelatin
goes into solution. Mississippi Agricultural and Forestry Experiment Station (MAFES)
primarily funded this project in order to support AgraTech International, Inc. (Denville,
NJ) for experimenting with improvement of the quality of chitosan produced by them.
Collaborating with the Biomaterials laboratory at Mississippi State University, chitosan
was made available by the manufacturer for its chemical analysis to determine
55
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DDA, moisture content, ash content, and protein content for the different batches of
chitosan. Hence the type of chitosan used for this project was dependant on its
availability from the manufacturer for testing purposes. Although the grade and purity of
chitosan was not evaluated by the researcher, it was known that no special manufacturing
conditions were maintained to produce medical or pharmaceutical grade chitosan thus
making the product more of an industrial grade. Also, since the manufacturer was in the
process of refining their chitosan production protocol the DDA of chitosan used for the
large batch tests was not known precisely before starting experiments. Based on earlier
batches it was not expected to be as low as 50-60%. This low DDA and extraneous
impurities in chitosan would have had some effect on cell attachment and overall
biocompatibility of scaffolds used for the large batch.
Scaffold sections from preliminary tests generally did not show much variation in
their pore sizes across a cross section. However, similar sections from scaffolds from
large batch showed large elongated pores localized near one surface. Since the freezing
rate and temperature were maintained same in both studies, the only explanation to this
may be the inhomogeneous mixture of chitosan and gelatin solutions in acetic acid for the
large batch scaffolds. Gel clumps that were formed in gelatin acetic acid solution
remained un-dissolved even after 30 min of vortexing. Loosely packed gelatin may have
tended to dissolve away from the scaffold while in culture and left behind large voids.
This would also have contributed to faster decrease in scaffold mass from dissolution and
this rate of dissolution was not well balanced with the rate of growth of new tissue.
Heating solutions to about 50º C is reported to form uniform chitosan gelatin
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polyelectrolyte complexes (Yin et al., 1999). Also aqueous gelatin solutions may be used,
if desired.
Objective 2: Effect of Gelatin Concentration on Chondrocyte Response
Scaffolds were prepared by blending chitosan and gelatin (1:1, 2:1, and 3:1 w/w)
and from 100% chitosan (control) solutions in 1% acetic acid. Hematoxylin and toluidine
blue staining showed a general gradation in the amounts of ECM secreted as the amount
of gelatin in scaffolds increased, having its maximum for 50% chitosan gelatin blends.
Yin et al (1999) observed similar trend from X-Ray diffraction analysis of chitosan
gelatin blends. As the gelatin proportion in chitosan scaffold approached 50% there was a
gradual smoothening of crystalline peaks in the diffraction patterns and better tensile
properties of films were seen. This trend was speculated to indicate optimum
compatibility between chitosan and gelatin material phases at room temperature. Further
Cheng et al. (2003) report an increase in the wettability of chitosan gelatin blends with
concentrations approaching 50% gelatin. Films made from these solutions showed better
elastic properties as compared to films from pure chitosan and pure gelatin.
The cell seeding density used for this study (25 x 103 cells/scaffold) was much
lower compared to that used in culturing the large batch (870 x 103 cells/scaffold) of 1:1
chitosan gelatin scaffolds and so results of sGAG/DNA from these studies may not be
directly compared to each other. These values for 1:1 chitosan gelatin scaffolds from
preliminary tests and that from the large batch are somewhat different due to different
sGAG quantification methods and types of component materials used in blends.
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To maximize cell loading and considering the initial apoptotic response of cells
when seeded on scaffold, care was taken to supplement fresh cells to the large batch
scaffolds, at intervals of few hours. Although, this may have facilitated initial loading of
cells into the scaffold, there were limitations to the depth of penetration of cells that could
be achieved from this static cell seeding technique. Introducing cells to the scaffold by
static techniques like pipetting would have caused many of them to fall off through the
scaffold pores and stick to the polystyrene well. Scaffolds having a more closed pore
structure may be constructed by increasing the freezing rate (decreasing freezing
temperature below -20º C) of solutions. On the other hand scaffolds that were set rotating
in a dense cell suspension showed almost uniform cell loading across cross sections after
1 day and was maintained until 3 days. Such cell seeding techniques may be followed in
future studies (Figure 12).
Objective 3: Test the Effect of Culture Technique on Generation of ECM
While culturing the large batch scaffolds in a bioreactor, the speed of rotation was
varied to maintain scaffolds in a constant state of drag/flow along with culture media.
This is recommended in order to avoid shearing effects from surrounding fluids.
Although, a state of free fall is recommended to have maximum benefits of mass
transport capabilities of the bioreactor, scaffolds set up in orbiting motion showed no
statistically significant difference in terms of the amount of cells, GAG, and collagen
secreted after 1 week (Freed and Vunjak-Novakovic 1995). In order to maintain sterility
of apparatus, half of the culture medium was changed once every week and ascorbate was
supplemented then. As indicated by Obradovic et al. (1999) such a protocol did not have
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any significant effect on the number of cells, GAG content, and wet weight of polymer
constructs after 5 weeks in culture as compared to those with typically 3 medium changes
per week.
Biochemical analysis after 3 weeks of culture revealed that transwell and
bioreactor scaffolds have nearly the same DNA content and GAG content of transwell
scaffolds is higher than those in bioreactor. Since, much of the sGAG secreted by the
growing chondrocytes are released into the culture media (Obradovic et al., 1999) higher
flow rates in bioreactor may be responsible for hindering the organization of ECM in the
scaffold. One important source of variability in data may be the sGAG quantification
methods. sGAG were estimated from each of the 4 quarters of scaffolds from transwell
(4x4 = 16) and summed up to give an estimate for that specific scaffold. On the other
hand, whole of the bioreactor scaffolds (n = 4) were used for this purpose. However, as
seen from histological staining, scaffolds in bioreactor generally appeared to have deeper
cell penetration and cells were viable after 3 weeks. Similarly, stained sections of
scaffolds in transwell constructs showed ECM concentrated mainly at surfaces and
boundaries with little to no penetration. Bioreactor scaffolds, on the other hand, had fairly
deep dispersion of cells and ECM secretion.
Cells that represent growth response or apoptosis response secrete certain
chemical factors in culture media that by either aid or hinder the growth of new cells. It
was observed that the amount of DNA obtained after 5 weeks in bioreactor culture was
slightly lesser (not statistically significant) than that obtained after 3 weeks (Figure 6).
Although this observation is limited by a small sample size (n=1), such a trend may
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suggest concentration of cell apoptosis factors in the culture media. Given that the half of
the bioreactor culture media was changed once a week (not replaced between 3rd and 5th
weeks) the possibility of initiation of an apoptotic cell response may not be ruled out.
There are certain limitations to the analysis of collagen content of cultured
scaffolds solely through immuno-histochemistry methods. This method gives insights
into the amount and extent of penetration of matrix contents across a specific section, it is
more often dependant on the site and orientation of the section. These limitations may be
overcomed, at least partially, by the use of quantitative assays for collagen measurement
(for example chloramine-T hydroxyproline assay).
Hu and Athanasiou (2005) report of a similar study involving 3D PGA scaffolds
that were cultured in static and bioreactor cultures in a rotating regimen with cell seeding
density comparable to this study. Bioreactor cultures did not appear to outperform static
cultures after 4 weeks of culture time, as indicated from the amount of sGAG and
collagen per dry weight of scaffolds. Similarly, scaffolds in static cultures were stiffer
than those in bioreactor. Factors like type of bioreactor, maintenance of gas and nutrient
perfusion levels, and hydrodynamic/flow parameters are to be judiciously selected and
controlled to have maximum benefit from this culture technique.
Testing the compressive elastic modulus of scaffolds seemed a good way to
analyze bulk properties of cultured constructs. Due to differences between individual
specimens, all mechanical tests were performed at a different starting thickness of
scaffolds. The reaction force encountered by the indenter compressing on scaffolds
served as a contact detection criterion. While studying stress relaxation response of
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scaffolds the indenter step size (constant strain) and speed of compression (strain rate)
were fixed. Hence the elastic moduli of scaffolds are a reliable measure to be compared
directly. Results show that the scaffolds left into static and dynamic culture conditions
without any cells on them, degraded in their mechanical properties between 3 and 5
weeks. However, culturing chondrocytes on them resulted in higher elastic moduli,
suggesting that cell culture resulted in growth of a mechanically strong neocartilagenous
tissue and/or at least prevented scaffold degradation from dissolution of gelatin.
Transwell scaffolds after 3 weeks of culture were mechanically stiffer as
compared to those in bioreactor (Figure 11). This may be attributed to low amounts of
ECM secretion/organization on bioreactor scaffolds. A bioreactor is expected to have
higher amounts of ECM secretion as a result of better mass and nutrient transport that is
achieved. However, hydrodynamic factors in culture may wash away newly secreted
ECM components and thus prevent its early organization in scaffold. Eventually as the
rate of matrix synthesis exceeds that of its dissolution the accumulation of ECM is seen.
With a control on gas and nutrient transfer and other hydrodynamic factors of bioreactor
culture, this study indicates that noticeable deposition of ECM may be seen after 5 weeks
or more. Consistently throughout the 5 weeks culture period the bioreactor culture
showed more uniform and deep penetration of ECM compared to static transwell culture.
Comparing the elastic moduli of scaffolds with and without cells from transwell
and bioreactor shows that culture of chondrocytes does enhance the mechanical
properties of scaffolds. In agreement with the results of Hu and Athanasiou (2005), this
study also indicates that bioreactor cultures did not outperform static cultures in terms of
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amount of sGAG quantified after culture. Whether this was due to the rotating regimen of
the scaffolds in bioreactor or degradation activity of chondrocytes or due to any other
factor, needs to be evaluated by further controlled studies.
Overall the mechanical properties of cultured chitosan gelatin scaffolds in this
study were not better to than those obtained from other studies involving chondrocyte
culture on polymer scaffolds in bioreactor (Vunjak-Novakovic et al., 2004). Differences
between both studies are apparent due to factors like high initial cell seeding density (3-5
million or more cells/scaffold in other studies versus less than 1million in this study), age
and species of animal source (calf versus adult pigs in this study). While some of these
other studies focus on in vitro growth of a nearly mature cartilaginous tissue, this study
was aimed at designing a biocompatible yet easily degradable cell culture construct. Such
a strategy would help in better and uniform integration of the construct with native
cartilage when implanted in vivo.
Cell Attachment Kinetics
In order to study the time course of cell attachment and viability into the scaffold,
they were set into a rotating motion in a dense cell suspension (5 x 106 cells/scaffold)
with conditions similar to a small volume bioreactor. Short-term evaluation, up to a week,
showed almost uniform cell dispersion across the cross section of scaffolds. Once such
uniform cell loading is achieved, the true potential of these 3D scaffolds to support
neochondrogenesis and ECM secretion may be evaluated from long culture times.
Gelatin filaments were seen entangled along with chitosan matrix after 4 days and
were almost extinct after 7 days in cell suspension to have a more open pore structure
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(Figure 12G). This correlates well with the observation that mechanical properties of
scaffolds with no cells in bioreactor did not show a noticeable degradation after 3 weeks
upto 5 weeks (Graph Figure 8). This indicates most of the gelatin component in scaffolds
was washed away by dissolution between 1 and 3 weeks. This degradation rate may be
slightly faster as compared to the rate of regeneration of new tissue. The inhomogeneous
mixture of chitosan gelatin in their blends may be responsible for weak binding between
them and hence faster washout of gelatin.
The tendency of gelatin of dissolve away from the blended scaffold may be
encouraging as it would leave behind a more open and interconnected chitosan network.
Pure chitosan is superbly biocompatible and supports chondrocyte growth and
proliferation (Nettles et al., 2002). Gelatin too does not pose hazards of any adverse
tissue response.
High positive charge density of chitosan is sometimes held responsible for the
severe cell apoptosis response on their contact with the biomaterial. Combination of
chitosan and gelatin is aimed to reduce the possibility of such response. By the time most
of the gelatin component of scaffolds would dissolve away chondrocyte colonies would
have started differentiating. The resultant open structure of the scaffold would help in
better gas and nutrient transfer to the growing cells that would eventually fill up the
pores. Such strategy may be advantageous as it would facilitate uniform distribution of
ECM once the rate of dissolution of gelatin is balanced with that of chondrocyte
proliferation.
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Chitosan (with specific DDA) and gelatin (from a source compatible to cells used
and with specific molecular weight) may be selected to control degradation of chitosan
gelatin scaffolds from cellular enzymatic activity. In order to control degradation from
dissolving, better initial binding between chitosan and gelatin should be achieved during
fabrication of polyelectrolyte complex from them. Heating the mixture of solutions (low
temperature around 50º C) and/or use of a carefully selected and biocompatible crosslinking agent may be helpful in this regard. Stiffer scaffolds or culture matrices are
reported to keep chondrocytes in a proliferative rather than differentiating phenotype,
thus resulting in less type II collagen secretion (Drury and Mooney, 2003). In order to
develop a better culture environment for chondrocytes in chitosan gelatin scaffolds, the
cross-linking density, scaffold composition, pore size and connectivity may be altered to
control their gross mechanical properties.
Future Direction of Work
The ultimate objective of this project is to build a construct for culturing
chondrocytes in vitro and potentially implanting it into a cartilage defect so that it may be
healed. As a first step towards this it is important to have confidence from the in vitro
response of cells to this composite biomaterial. Factors like selection and processing of
component materials to form scaffolds and the hydrodynamic and mechanical
stimulations obtained from the culturing technique may be optimized and controlled to
have the desired tissue growth. The in vivo biocompatibility could be evaluated by
implanting scaffolds in subdermal pouches in a small animal model (such as nude mice).
This may be followed by an evaluation of the in vivo chondrogenic efficacy and long-
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term performance of construct to fill in cartilage defects by implanting the cultured
scaffolds in an artificially created subchondral bone defect in a large animal (such as
rabbit) model.

CHAPTER V
CONCLUSION

This study demonstrated the potential of 3D chitosan gelatin complex scaffolds
for culturing articular chondrocytes. Selecting chitosan and gelatin from proper source
and with known chemical properties,porous scaffolds can be easily constructed from their
blends. Of the different combinations of chitosan and gelatin blends that were tested the
ones with 50% gelatin showed maximum biosynthetic activity of the seeded
chondrocytes after 3 weeks in culture. The presence of gelatin in chitosan scaffolds had a
small but noticeable effect on growth of chondrocytes. Moreover, gelatin served as a
leeching agent that dissolved in culture media leaving behind a more open and
interconnected chitosan scaffold structure. Overall chitosan gelatin scaffolds showed
better performance in culturing chondrocytes as compared to pure chitosan scaffolds.
Evaluating the effect cast due to the culturing technique, the scaffolds in
bioreactor culture for small period up to 3 weeks did not outperform those in transwell
culture in terms of the amount of sulphated glycosaminoglycans secreted and the overall
mechanical properties of scaffolds. Results indicate that longer culture periods (5 weeks
or more) may be required to see a noticeable effect on extra cellular matrix secretion in
the bioreactor culture.
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CONSIDERATIONS

76

77
Structure
Articular cartilage is an aneural, avascular, and alymphatic tissue covering the
interfacing ends of bones in diarthrodial joints. It is the smooth, pearly white layer that
lubricates joint motion by preventing direct rubbing of the hard bony tissue against each
other. Moreover it plays a vital role in load bearing and load transfer across the joints. Its
thickness and quality varies from joint to joint and from the location in a single joint.
Other factors like the age and species of animal source, body mass, physical activity and
presence of diseased conditions that influence the quality of cartilage tissue.
Essentially, articular cartilage is made up of a single type of cells, called
chondrocytes, embedded in a sea of extra-cellular matrix that is secreted by them. The
variation of the chemical composition of the matrix (with age, physical activity, location
in tissue etc.) and the changes in morphology and activity of the chondrocytes makes the
tissue biologically more complex than expected. The matrix mainly consists of water (6580% of wet weight), proteoglycans, collagens (50% dry weight) and some other proteins
and glycoproteins. The unique biomechanical characteristics of the tissue are attributed to
its viscoelasticity, anisotrophy, inhomogeneity and nonlinearity in mechanical properties
(Guilak, 2004) of the matrix.
Articular cartilage may be divided into 4 distinct zones according to the
morphology of chondrocytes in different layers and the variation in chemical composition
of these layers. Going from superficial to deep into the tissue the four layers are surface
layer, middle layer, deep layer and finally the zone of calcified cartilage at the interface
of cartilage with subchondral bone (Poole, 1993). A detailed study of the chondrocyte
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morphology across the thickness of cartilage reveals that they oriented along the lines of
maximum force that is subjected at that region in the matrix.

Table 4: Summary of different zones in articular cartilage. Modified from Poole A.C.
(1993) and Buckwalter J.A. (2004)
Zones
Properties

Zone I
(Superficial)

Zone II
(Middle)

Zone III
(Deep)

Volume

5-10%

40-45%

40-45%

Zone IV
(Calcified
Cartilage)
5-10%

Chondrocyte

Thin and

morphology

discoid

Round

Spheroidal

Small & rounded

Chondrocyte

Parallel to

Disperse

Arranged in

Random &

orientation

surface

columns

encased in
calcified cocoon

Collagen fibers

Uniform sheet

Amorphous

Radially

tangential to

network of

aligned fibers

surface

oblique fibrils

Large diameter

Water content

Highest (80%)

High

Lowest (65%)

Proteoglycan

Lowest

High

Highest

Radialy aligned

Absent

Chondrocytes: Biomechanical Response
Chondrocytes are the only type of cells present in the cartilage but account for
less then 10% of the total matrix volume. A balance between their anabolic and catabolic
activities helps to maintain the cartilaginous matrix. Since there are no inter or intra
cellular vascular connections between them most of the transfer of gasses and nutrients
takes place by diffusion through the synovium and bone vasculature. Their anaerobic
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metabolism renders them to be metabolically less active and less sensitive to loading and
injury compared to bone and muscle cells (Buckwalter, 2004).
The stress environment within the joint and the ability of chondrocytes to regulate
their metabolism provides them a means to regulate the structure and composition of
cartilage matrix depending on the requirements of the body. The chondrocytes respond to
hydrostatic loading effect on the matrix and its components due to externally applied
load. Their metabolic activity and cell differentiation are modulated by integrin and other
adhesion mediators. High frequency oscillating loads stimulates matrix synthesis as
compared to static loads or low frequency hydrostatic loading (Elder at al., 2005,
Caterson et al., 2004). Poole (1993) emphasizes on chondron, the periarticular
environment of chondrocytes, to be the functional and metabolic unit acting as a
transducer for maintaining of cartilage homeostasis.
Under certain abnormal conditions like disease or excessive tissue injury may
lead to initiation of inflammation and degradation process eventually leading to joint
degeneration (Guilak, 2004).

APPENDIX B
MECHANICAL TESTING OF CHITOSAN GELATIN
SCAFFOLDS
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Figure 16: Compressive resilience testing on scaffolds before (A) and after 3 weeks in
static culture (B) and bioreactor (C) without cells.
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Figure 17: Compressive resilience testing on scaffolds after 5 weeks in bioreactor without
cells.
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Figure 18: Compressive resilience tests after culturing chondrocytes on scaffolds for 3
weeks in transwell (A) and bioreactor (B) and after 5 weeks in bioreactor (C).
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